Why the study?
Few studies have examined the characteristics of catheter ablation vascular complications amid the increasing use of CTA for diagnosis.
What is the incidence of femoral vascular complications after catheter ablation and what factors are associated with them?
What is the incidence of femoral vascular complications after catheter ablation and what factors are associated with them?
Major femoral vascular complications occur in 1.6% of catheter ablation patients, with risk increased by antiplatelet therapy and larger arterial sheaths, and CTA is useful for rapid diagnosis.
Supports minimizing larger sheaths and antiplatelet therapy in ablation; leaves open prospective validation of risk mitigation.
BACKGROUND: Few studies have examined the characteristics of catheter ablation vascular complications, and recently physicians increasingly use computed tomography angiography (CTA) for diagnosing. OBJECTIVE: We sought to investigate the incidence of femoral vascular complications in catheter ablation and factors associated with complications in the current era. METHODS: This single-center observational study consisted of 311 consecutive (atrial fibrillation, atrial flutter, paroxysmal supraventricular tachycardia, and ventricular arrhythmias in 222 [71.4%], 7 [2.3%], 43 [13.8%], and 39 [12.5%]) patients who underwent catheter ablation. The detailed patient data and clinical outcomes were obtained from the medical records. RESULTS: Emergent CTA was performed in a total of 8 (2.6%) patients at a median of 4.5 (2.0-12.5) days postprocedure, and the precise diagnosis was obtained in all. Among them, pseudoaneurysms, arteriovenous fistulae (AVF), and actively bleeding hematomas were identified in two, one, and one patient, respectively, and all required readmissions after discharge. AVF was diagnosed by a Doppler ultrasound examination in another patient. In total, 5 (1.6%) patients exhibited major femoral vascular complications including two pseudoaneurysms, two AVFs, and one active bleeding hematoma. The pseudoaneurysms and AVFs were successfully eliminated by direct compression, and extravasation from the femoral circumflex artery required coil embolization. Antiplatelet therapy and the use of larger arterial sheaths (≥7-Fr) increased the major femoral arterial complications, but atrial fibrillation ablation under uninterrupted anticoagulation therapy or the use of larger venous sheaths did not. CONCLUSION: Vascular complications are still not negligible procedure-related complications during catheter ablation in the current era. CTA provides a rapid and precise diagnosis for optimal treatment strategies.
No takes yet. Share an insight, caveat, or question.
Ishikawa et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: